Quest Diagnostics
DGX
#1089
Rank
$17.28 B
Marketcap
$154.83
Share price
-0.71%
Change (1 day)
19.01%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Quest Diagnostics (DGX) - Net assets

Net assets on the balance sheet as of September 2024 : $6.92 Billion USD

According to Quest Diagnostics 's latest financial reports the company has $6.92 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Quest Diagnostics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$$6.41 B6.84%
2022-12-31$$6.00 B-8.46%
2021-12-31$$6.56 B-4.77%
2020-12-31$$6.89 B19.57%
2019-12-31$$5.76 B7.84%
2018-12-31$$5.34 B6.14%
2017-12-31$$5.03 B6.29%
2016-12-31$$4.73 B-0.96%
2015-12-31$$4.78 B10.46%
2014-12-31$$4.33 B8.99%
2013-12-31$$3.97 B-5.09%
2012-12-31$$4.18 B12.68%
2011-12-31$$3.71 B-8.36%
2010-12-31$$4.05 B1.06%
2009-12-31$$4.01 B11.28%
2008-12-31$$3.60 B8.44%
2007-12-31$$3.32 B10.1%
2006-12-31$$3.01 B9.27%
2005-12-31$$2.76 B20.73%
2004-12-31$$2.28 B-4.43%
2003-12-31$$2.39 B35.38%
2002-12-31$$1.76 B32.4%
2001-12-31$$1.33 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
$8.02 B 15.89%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.74 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.91 B-86.77%๐Ÿ‡บ๐Ÿ‡ธ USA
$69.03 M-99.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.40 B-50.80%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands